Search

Search Constraints

You searched for: Author/Creator Raftopoulos, Harry

Search Results

1. Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study. Issue 11 (November 2016)

2. Correction to: Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop. Issue 1 (4th July 2019)

5. Pembrolizumab and platinum-based chemotherapy as first-line therapy for advanced non–small-cell lung cancer: Phase 1 cohorts from the KEYNOTE-021 study. (November 2018)

6. Pembrolizumab in combination with ipilimumab as second-line or later therapy for advanced non–small-cell lung cancer: KEYNOTE-021 cohorts D and H. (April 2019)

8. Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop. Issue 1 (22nd May 2019)